Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Elena Urbieta"'
Autor:
Celia García-Molina Sáez, Elena Urbieta Sanz, Manuel Madrigal de Torres, Pascual Piñera Salmerón, María D. Pérez Cárceles
Publikováno v:
Atención Primaria, Vol 48, Iss 3, Pp 183-191 (2016)
Objetivo: Cuantificar y evaluar la fiabilidad de los registros electrónicos de medicación de Atención Primaria (AP) como fuente de información de la medicación crónica del paciente, así como identificar los factores asociados a la presencia de
Externí odkaz:
https://doaj.org/article/a509691d8bc34f9586db6580435f649b
Publikováno v:
Farmacia Hospitalaria, Vol 42, Iss 03, Pp 135-136 (2018)
Externí odkaz:
https://doaj.org/article/53f1198939e14fc99146023d5467cbf4
Autor:
María Onteniente-Candela, Elena Urbieta-Sanz, Juan José Gascón-Cánovas, Lorena Rentero-Redondo, Mayte Gil-Candel, Carles Iniesta-Navalón
Publikováno v:
International Journal of Clinical Pharmacy. 42:500-507
Background Conventional therapy of inflammatory bowel disease with traditional immunosuppressant medication is increasingly being replaced by biological agents. However, the response to these biological agents may be lost over time, with discontinuat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::561a7845039038b7c68fa73a389907cf
https://doi.org/10.1007/s11096-020-00978-6
https://doi.org/10.1007/s11096-020-00978-6
Autor:
Isabel Nicolás de Prado, Elena Urbieta Sanz, Carles Iniesta Navalón, Rosa Gómez Espín, Juan José Gascón Cánovas, Mayte Gil Candel
Publikováno v:
Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva. 112(5)
Introduction: previous studies have shown that higher infliximab trough levels are associated with favorable short-term and long-term therapeutic outcomes in inflammatory bowel disease. There is a need to determine which patients could benefit from p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89f9dfcccdb405f8aa9dd46d814d8bec
https://pubmed.ncbi.nlm.nih.gov/32338010
https://pubmed.ncbi.nlm.nih.gov/32338010
Autor:
Isabel Nicolás de Prado, Carles Iniesta Navalón, Juan José Gascón Cánovas, Rosa Gómez Espín, Elena Urbieta Sanz, Mayte Gil Candel, Lorena Rentero Redondo
Publikováno v:
Revista Española de Enfermedades Digestivas. 112
Introduction: infliximab is used in inflammatory bowel disease, which has a great inter-individual pharmacokinetic variability. Thus, it is necessary to individualize the therapy in many cases. The main objective of our study was to compare two metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9c092a1ef7e88b7fd2ff024ed7d6c88
https://doi.org/10.17235/reed.2020.6857/2020
https://doi.org/10.17235/reed.2020.6857/2020
Publikováno v:
Jounal of Negative and No Positive Results, Vol 2, Iss 11, Pp 644-646 (2017)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::9e407918da7b43d1d135c9aca961721e
https://www.jonnpr.com/pdf/1893.pdf
https://www.jonnpr.com/pdf/1893.pdf
Autor:
Juan José Gascón Cánovas, Carles Iniesta Navalón, Carmen Caballero Requejo, Elena Urbieta Sanz
Publikováno v:
Atencion Primaria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c4bd9761db5c293a40202ae81397352
https://doi.org/10.1016/j.aprim.2018.11.004
https://doi.org/10.1016/j.aprim.2018.11.004
Publikováno v:
Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias. 27(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6e46e675b3ee9636ecb6e1b01006fcab
https://pubmed.ncbi.nlm.nih.gov/29077321
https://pubmed.ncbi.nlm.nih.gov/29077321
Publikováno v:
Farmacia Hospitalaria, Vol 41, Iss 5, Pp 642-643 (2017)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::d8e02a89765a3c3501b2df02ac7dec66
https://pubmed.ncbi.nlm.nih.gov/28847256
https://pubmed.ncbi.nlm.nih.gov/28847256
Autor:
Carles Iniesta-Navalón, Elena Urbieta-Sanz, Juan B Cabezuelo-Romero, Aurelio Cabello-Muriel, Juan José Gascón-Cánovas
Publikováno v:
European Journal of Hospital Pharmacy. 22:23-27
Objective To evaluate the similarity (or not) of the dose recommendations according to the Cockcroft–Gault and MDRD4 (modified diet in renal disease) equations. Method A cross-sectional comparative observational test of patients suffering chronic r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::55ea6294287be754b36e3d326223a5de
https://doi.org/10.1136/ejhpharm-2014-000466
https://doi.org/10.1136/ejhpharm-2014-000466